High-intensity focused ultrasound therapy

Area of Science:

• Reproductive Medicine
• Minimally Invasive Therapies
• Medical Imaging

Background:

• Benign uterine tumors, including fibroids and adenomyosis, significantly impact women's health.
• High-intensity focused ultrasound (HIFU) therapy is emerging as a key treatment modality.
• Imaging guidance (MRI or ultrasound) is crucial for targeting and monitoring HIFU ablation.

Purpose of the Study:

• To provide a comprehensive overview of HIFU for uterine fibroids and adenomyosis.
• To review treatment outcomes, safety, and clinical trial data.
• To discuss HIFU's potential as a uterus-sparing alternative.

Main Methods:

• Literature review of background, clinical use, and outcomes.
• Analysis of clinical trials comparing HIFU with other interventions.
• Focus on magnetic resonance-guided (MRgFUS) and ultrasound-guided (USgFUS) HIFU.

Main Results:

• HIFU demonstrates efficacy in managing uterine fibroids and adenomyosis.
• Clinical trials show comparable or improved outcomes for HIFU versus traditional methods.
• Safety profiles are generally favorable, with manageable side effects.

Conclusions:

• High-intensity focused ultrasound is a viable uterus-sparing option for benign uterine conditions.
• MRgFUS and USgFUS offer effective, minimally invasive treatment pathways.
• Further research supports HIFU's role in conservative management of uterine pathologies.